Chimerix Inc (CMRX)
0.9529
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.9548
0.00 (0.00%)
After-Hours: 20:00
Chimerix Free Cash Flow: -69.18M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -69.18M |
| September 30, 2023 | -74.58M |
| June 30, 2023 | -49.57M |
| March 31, 2023 | -45.78M |
| December 31, 2022 | -46.94M |
| September 30, 2022 | -60.99M |
| June 30, 2022 | -83.34M |
| March 31, 2022 | -85.61M |
| December 31, 2021 | -100.14M |
| September 30, 2021 | -75.14M |
| June 30, 2021 | -68.20M |
| March 31, 2021 | -63.24M |
| December 31, 2020 | -36.10M |
| September 30, 2020 | -30.53M |
| June 30, 2020 | -64.34M |
| March 31, 2020 | -70.34M |
| December 31, 2019 | -75.34M |
| September 30, 2019 | -80.18M |
| June 30, 2019 | -50.96M |
| March 31, 2019 | -51.18M |
| December 31, 2018 | -53.91M |
| September 30, 2018 | -57.83M |
| June 30, 2018 | -56.28M |
| Date | Value |
|---|---|
| March 31, 2018 | -55.20M |
| December 31, 2017 | -50.28M |
| September 30, 2017 | -47.81M |
| June 30, 2017 | -49.61M |
| March 31, 2017 | -49.42M |
| December 31, 2016 | -64.66M |
| September 30, 2016 | -88.62M |
| June 30, 2016 | -100.98M |
| March 31, 2016 | -112.00M |
| December 31, 2015 | -102.10M |
| September 30, 2015 | -85.55M |
| June 30, 2015 | -71.92M |
| March 31, 2015 | -57.85M |
| December 31, 2014 | -48.10M |
| September 30, 2014 | -37.76M |
| June 30, 2014 | -31.03M |
| March 31, 2014 | -28.87M |
| December 31, 2013 | -25.75M |
| September 30, 2013 | -23.55M |
| June 30, 2013 | -6.074M |
| March 31, 2013 | -3.187M |
| December 31, 2012 | -2.002M |
Free Cash Flow Range, Past 5 Years
-100.14M
Minimum
Dec 2021
-30.53M
Maximum
Sep 2020
-64.76M
Average
-68.20M
Median
Jun 2021
Free Cash Flow Benchmarks
| UFP Technologies Inc | 30.84M |
| Dentsply Sirona Inc | 279.00M |
| Arbutus Biopharma Corp | -86.94M |
| Pacira BioSciences Inc | 139.49M |
| Karyopharm Therapeutics Inc | -92.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.59M |
| Cash from Investing (Quarterly) | 28.07M |
| Cash from Financing (Quarterly) | 0.062M |
| Free Cash Flow Per Share (Quarterly) | -0.1641 |
| Free Cash Flow to Equity (Quarterly) | -14.59M |
| Free Cash Flow to Firm (Quarterly) | -14.59M |
| Free Cash Flow Yield | -81.93% |